ArticleExpert systems2022
Deming least square regressed feature selection and Gaussian neuro-fuzzy multi-layered data classifier for early COVID prediction.
Article in Expert systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- COVID-19 detection from chest X-ray images using CLAHE-YCrCb, LBP, and machine learning algorithms.BMC bioinformatics · 2024Article
- GUI Enabled Optimized Approach of CNN for Automatic Diagnosis of COVID-19 Using Radiograph Images.New generation computing · 2023Article
- A new parallel multi-objective Harris hawk algorithm for predicting the mortality of COVID-19 patients.PeerJ. Computer science · 2023Article
- Deming least square regressed feature selection and Gaussian neuro-fuzzy multi-layered data classifier for early COVID prediction.Expert systems · 2022Article
- Quantum Edge Extraction of Chest CT Image for the Detection and Differentiation of Infected Region of COVID-19 Patient.Arabian journal for science and engineering · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease (COVID-19) is a harmful disease caused by the new SARS-CoV-2 virus. COVID-19 disease comprises symptoms such as cold, cough, fever, and difficulty in breathing. COVID-19 has affected many countries and their spread in the world has put humanity at risk. Due to the increasing number of cases and their stress on administration as well as health professionals, different prediction techniques were introduced to predict the coronavirus disease existence in patients. However, the accuracy was not improved, and time consumption was not minimized during the disease prediction. To address these problems, least square regressive Gaussian neuro-fuzzy multi-layered data classification (LSRGNFM-LDC) technique is introduced in this article. LSRGNFM-LDC technique performs efficient COVID prediction with better accuracy and lesser time consumption through feature selection and classification. The preprocessing is used to eliminate the unwanted data in input features. Preprocessing is applied to reduce the time complexity. Next, Deming Least Square Regressive Feature Selection process is carried out for selecting the most relevant features through identifying the line of best fit. After the feature selection process, Gaussian neuro-fuzzy classifier in LSRGNFM-LDC technique performs the data classification process with help of fuzzy if-then rules for performing prediction process. Finally, the fuzzy if-then rule classifies the patient data as lower risk level, medium risk level and higher risk level with higher accuracy and lesser time consumption. Experimental evaluation is performed by Novel Corona Virus 2019 Dataset using different metrics like prediction accuracy, prediction time, and error rate. The result shows that LSRGNFM-LDC technique improves the accuracy and minimizes the time consumption as well as error rate than existing works during COVID prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.